Thesis (MSc)--Stellenbosch University, 2015. / ENGLISH ABSTRACT: Targeted therapy for prostate cancer may offer potential improvement over current
conventional therapies because of its specificity. Although conventional treatments
are effective, they are not curative and have several limitations. In prostate cancer,
activation of both the epidermal growth factor receptor (EGFR) and the
phosphatidylinositol 3 – kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway have been implicated in tumorigenesis and resistance to both conventional
and targeted anticancer therapies. Having a better understanding of the molecular
mechanisms involved in PCa development, progression and resistance to therapy,
could assist in the design of novel therapeutic strategies.
The objective of this study was to inhibit key molecular targets of the human
epidermal growth factor receptor signalling pathway and expose prostate cell lines to
doses of radiation, so as to establish potential therapeutic targets that may be
amenable to combined modality therapy, and formulate a cocktail of inhibitors to
evaluate its radiosensitising capability.
The EGFR/PI3K/mTOR pathway plays an important role in the radiosensitivity of the
human prostate carcinoma cell line (DU145) and the normal cell line (1542N). In our
study we have shown that AG-1478, an EGFR inhibitor, and BEZ-235, a dual
inhibitor of the PI3K/mTOR pathway, singly or in combination, at low and relatively
high radiation doses, resulted in radiosensitisation of DU145 cells. Radio-protection
was achieved in 1542N cells. AG-1478 had no effect on radiosensitivity. / AFRIKAANSE OPSOMMING: Geteikende terapies wens hul spesifisiteit teenoor konvensionele terapies vir
prostaat kanker, mag potensieel verbetering offer. Konvensionele behandeling is wel
effektief maar nie genesend nie wens ‘n aantal beperkings, sowel as die toksisiteit vir
normale selle. In prostaat kanker is die aktivering van beide die epidermiese groei
faktor reseptor (EGFR) en fosfatidielinositol 3-kinase/Akt/soogdier teiken vir rapamisien
(mTOR) seingewing baan sterk betrek by tumor groeisel en weerstand teen
konvensionele en geteikende anti-kanker terapies.
Beter begrip van die molekulêre meganismes betrokke by prostaat kanker
ontwikkeling, bevordering en weerstand teen terapie, kan die ontwerp van nuwe
terapeutiese strategies ondersteun.
Die doelwit van hierdie studie was om sleutel molekulêre teikens van die
epidermiese groei faktor reseptor seingewing baan te inhibeer en om prostaat selle
bloot te stel aan dosisse bestraling, om potensiële terapeutiese teikens te vestig wat
vatbaar is vir gekombineerde modaliteit terapie, om ‘n mengsel van stremmiddels te
formuleer, en om die straling gevoeligmaking bekwaamheid daarvan te evalueer.
Die EGFR/PI3K/mTOR seingewingbaan speel ‘n belangrike rol in the radiosensitiwiteit van
die menslike prostaat kanker sellyn (DU145) en die normale prostaat sellyn (1542N). Die
studie bevind dat AG-1478, ‘n EGFR stremmer, en BEZ-235, ‘n tweevoudige beperker van
die fosforinositied 3-kinase (PI3K) en soogdier teiken vir rapamisien (mTOR)
seingewingbaan, enkel of in kombinasie die DU145 selle radiosensitiseer vir straling dosisse
van 2 en 6 Gy. Stralings beskerming was verkry met die 1542N sellyn. AG-1478 het geen
effek getoon op radiosensitiwiteit nie.
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:sun/oai:scholar.sun.ac.za:10019.1/96854 |
| Date | 04 1900 |
| Creators | Maleka, Sechaba |
| Contributors | Akudugu, J. M., Serafin, A. M., Stellenbosch University. Faculty of Health Sciences. Dept. of Medical Imaging and Clinical Oncology. Nuclear Medicine. |
| Publisher | Stellenbosch : Stellenbosch University |
| Source Sets | South African National ETD Portal |
| Language | en_ZA |
| Detected Language | English |
| Type | Thesis |
| Format | 59 pages : illustrations |
| Rights | Stellenbosch University |
Page generated in 0.002 seconds